Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy

Breast cancer guidelines advise sentinel lymph node biopsy (SLNB) in patients with ductal carcinoma in situ (DCIS) on core biopsy at high risk of invasive cancer or in case of mastectomy. This study investigates the incidence of SLNB and SLN metastases and the relevance of indications in guidelines...

Descripción completa

Detalles Bibliográficos
Autores principales: van Roozendaal, L. M., Goorts, B., Klinkert, M., Keymeulen, K. B. M. I., De Vries, B., Strobbe, L. J. A., Wauters, C. A. P., van Riet, Y. E., Degreef, E., Rutgers, E. J. T., Wesseling, J., Smidt, M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837213/
https://www.ncbi.nlm.nih.gov/pubmed/27083179
http://dx.doi.org/10.1007/s10549-016-3783-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837213/
https://www.ncbi.nlm.nih.gov/pubmed/27083179
http://dx.doi.org/10.1007/s10549-016-3783-2

Ejemplares similares